Real-World Experiences With a Direct-Acting Antiviral Agent for Patients With Hepatitis C Virus Infection

CONTEXT: Traditional hepatitis C virus treatment was limited by low cure rates, side effects, and stringent monitoring requirements. Sofosbuvir, a direct-acting antiviral agent with a cure rate of 96%, was introduced in 2013. However, trials frequently excluded patients with advanced liver disease a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Perm J
Glavni autori: Louie, Vincent, Latt, Nyan L, Gharibian, Derenik, Sahota, Amandeep, Yanny, Beshoy T, Mittal, Rasham, Bider-Canfield, Zoe, Cheetham, T Craig
Format: Artigo
Jezik:Inglês
Izdano: The Permanente Journal 2017
Teme:
Original Research & Contributions
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378486/
https://ncbi.nlm.nih.gov/pubmed/28368787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/16-096
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items